236 related articles for article (PubMed ID: 11831064)
1. [Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Schilling D; Messerer P; Ott MG; Schauwecker P; Zober A; Riemann JF
Med Klin (Munich); 2002 Jan; 97(1):6-11. PubMed ID: 11831064
[TBL] [Abstract][Full Text] [Related]
2. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Gisbert JP; Marcos S; Gisbert JL; Pajares JM
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
[TBL] [Abstract][Full Text] [Related]
4. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
6. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
Babu V; Kate V; Ananthakrishnan N
Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
[TBL] [Abstract][Full Text] [Related]
7. Association of CagA-positive and CagA-negative Helicobacter pylori strains with patients' symptoms and gastritis in primary care patients with functional upper abdominal complaints.
Heikkinen M; Mayo K; Mégraud F; Vornanen M; Marin S; Pikkarainen P; Julkunen R
Scand J Gastroenterol; 1998 Jan; 33(1):31-8. PubMed ID: 9489905
[TBL] [Abstract][Full Text] [Related]
8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
9. Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease.
Saxena A; Shukla S; Prasad KN; Ghoshal UC
Indian J Med Res; 2011 May; 133(5):514-20. PubMed ID: 21623037
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Vasapolli R; Malfertheiner P; Kandulski A
Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
[TBL] [Abstract][Full Text] [Related]
11. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.
Trespi E; Broglia F; Villani L; Luinetti O; Fiocca R; Solcia E
Scand J Gastroenterol; 1994 Oct; 29(10):884-8. PubMed ID: 7839094
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia.
Goddard AF; Logan RP; Lawes S; Spiller RC
Aliment Pharmacol Ther; 1999 May; 13(5):637-42. PubMed ID: 10233187
[TBL] [Abstract][Full Text] [Related]
13. CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings.
Demirtürk L; Ozel AM; Yazgan Y; Solmazgül E; Yildirim S; Gültepe M; Gürbüz AK
Helicobacter; 2001 Jun; 6(2):163-8. PubMed ID: 11422473
[TBL] [Abstract][Full Text] [Related]
14. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
15. Specific Helicobacter pylori antigens unable to distinguish nonucler dyspepsia or peptic ulcer cases from asymptomatic seropositive controls: a nested case-control study in employees of a large company.
Schilling D; Ott MG; Nilius M; Köhler G; Zober A; Messerer P; Riemann JF
Dig Dis Sci; 2000 Dec; 45(12):2444-50. PubMed ID: 11258573
[TBL] [Abstract][Full Text] [Related]
16. [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Labenz J; Peitz U; Tillenburg B; Becker T; Börsch G; Stolte M
Leber Magen Darm; 1995 May; 25(3):122, 125-7. PubMed ID: 7609590
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Chuang CH; Sheu BS; Yang HB; Wu JJ; Lin XZ
Dig Liver Dis; 2001 Mar; 33(2):125-30. PubMed ID: 11346139
[TBL] [Abstract][Full Text] [Related]
18. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
Gisbert JP; Hermida C; Pajares JM
Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
[TBL] [Abstract][Full Text] [Related]
19. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Helicobacter pylori in Georgian patients with dyspepsia.
Olivares A; Buadze M; Kutubidze T; Lobjanidze M; Labauri L; Kutubidze R; Chikviladze D; Zhvania M; Kharzeishvili O; Lomidze N; Perez-Perez GI
Helicobacter; 2006 Apr; 11(2):81-5. PubMed ID: 16579837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
